ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
67 348,38
0,61%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Eli Lilly And Co (0Q1G)

  7. Eli Lilly And Co (0Q1G) Actualités

0Q1G

Eli Lilly (0Q1G)

Eli Lilly And Co
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0Q1G
DateHeureSourceTitreSymboleSociété
15/05/202422h07Alliance NewsAlliance NewsEli Lilly reaches settlement with Totality MedispaLSE:0Q1GEli Lilly And Co
30/04/202414h26Alliance NewsAlliance NewsTOP NEWS: Eli Lilly lifts outlook, ramps up production to meet demandLSE:0Q1GEli Lilly And Co
08/03/202416h16Alliance NewsAlliance NewsEli Lilly's Donanemab Alzheimer's drug hit by delaysLSE:0Q1GEli Lilly And Co
06/02/202413h44Alliance NewsAlliance NewsTOP NEWS: Eli Lilly eyes beefier sales amid weight loss drug crazeLSE:0Q1GEli Lilly And Co
26/01/202407h04Alliance NewsAlliance NewsEli Lilly weight loss drug could be supplied to UK 'in weeks'LSE:0Q1GEli Lilly And Co
23/01/202419h48Alliance NewsAlliance NewsIN BRIEF: Eli Lilly hails upbeat trial data for hearing loss therapyLSE:0Q1GEli Lilly And Co
17/11/202315h18Alliance NewsAlliance NewsTOP NEWS: Eli Lilly to invest USD2.5 billion in GermanyLSE:0Q1GEli Lilly And Co
09/11/202307h09Alliance NewsAlliance NewsEli Lilly diabetes drug authorised for weight management, loss in UKLSE:0Q1GEli Lilly And Co
08/11/202321h15Alliance NewsAlliance NewsUS approves highly anticipated Eli Lilly weight loss drugLSE:0Q1GEli Lilly And Co
02/11/202312h42Alliance NewsAlliance NewsTOP NEWS: Eli Lilly cuts yearly outlook on chunky R&D costsLSE:0Q1GEli Lilly And Co
08/08/202313h23Alliance NewsAlliance NewsTOP NEWS: Eli Lilly second quarter profit up, notes pipeline successesLSE:0Q1GEli Lilly And Co
21/06/202320h34Alliance NewsAlliance NewsUS FDA approves Eli Lilly's Jardiance drug for diabetes in childrenLSE:0Q1GEli Lilly And Co
27/04/202314h28Alliance NewsAlliance NewsTOP NEWS: Eli Lilly quarterly revenue down on reduced Covid-19 demandLSE:0Q1GEli Lilly And Co
03/03/202322h20Alliance NewsAlliance NewsIN BRIEF: US FDA approves expanded indication for Eli Lilly's VerzenioLSE:0Q1GEli Lilly And Co
01/03/202314h42Alliance NewsAlliance NewsUS drugmaker Eli Lilly says slashing insulin prices by 70%LSE:0Q1GEli Lilly And Co
02/02/202321h17Alliance NewsAlliance NewsEli Lilly & Co sees quarterly revenue fall amid declining volumesLSE:0Q1GEli Lilly And Co
01/11/202217h24Alliance NewsAlliance NewsEli Lilly lowers full year guidance despite positive earnings figuresLSE:0Q1GEli Lilly And Co
04/08/202213h23Alliance NewsAlliance NewsTOP NEWS: Eli Lilly cuts annual guidance as second quarter disappointsLSE:0Q1GEli Lilly And Co
03/02/202216h17Alliance NewsAlliance NewsEli Lilly sees net income fall but outlook for 2022 remains unchangedLSE:0Q1GEli Lilly And Co
 Showing the most relevant articles for your search:LSE:0Q1G

Dernières Valeurs Consultées

COIN
AGIXETH
SingularityNET Token
NYSE
DFEM
Dimensional ETF
LATK
DERIUSDT
Deri
XE
MTX
MTU Aero Engines
COIN
EBKCGBP
BIT
UC59X5
Unicredit Bank
BOV
ITUBT363
ITUBT363 Ex:34,91
LSE
SBAE
Ls -1x Alibaba
LQID
FTTJPY
FTX Token
NASDAQ
CACG
Legg Mason ETF Investmen...
COIN
EAURICGBP
Eauric
NASDAQ
HTCR
HeartCore Enterprises
BIT
UV4KXN
UniCredit Bank
GATE
SANDUSD
Sandbox
LSE
YJ88
Scot Hy El T 28
KOSPI
75602BA2
RK Real Estate No 3 Clas...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés